Free Trial
OTCMKTS:RHHBY

Roche (RHHBY) Stock Price, News & Analysis

Roche logo
$41.15 +0.47 (+1.16%)
As of 02/20/2025 04:44 PM Eastern

About Roche Stock (OTCMKTS:RHHBY)

Key Stats

Today's Range
$40.52
$41.18
50-Day Range
$34.24
$41.29
52-Week Range
$29.20
$42.43
Volume
591,871 shs
Average Volume
1.31 million shs
Market Capitalization
$262.45 billion
P/E Ratio
N/A
Dividend Yield
2.04%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Receive RHHBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

RHHBY Stock News Headlines

Roche unveils its breakthrough proprietary SBX technology
Grab This Altcoin Before Trump's Crypto Announcement
Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.
Critical Comparison: FibroGen (NASDAQ:FGEN) & Roche (OTCMKTS:RHHBY)
Morgan Stanley Begins Coverage on Roche (OTCMKTS:RHHBY)
See More Headlines

RHHBY Stock Analysis - Frequently Asked Questions

Roche's stock was trading at $34.88 on January 1st, 2025. Since then, RHHBY shares have increased by 18.0% and is now trading at $41.15.
View the best growth stocks for 2025 here
.

Roche subsidiaries include Inflazome, Stratos Genomics, Promedior, Spark Therapeutics, Tusk Therapeutics, Flatiron Health, Ignyta, and others.

Top institutional shareholders of Roche include Aristotle Capital Management LLC (0.04%), Saratoga Research & Investment Management (0.03%), Boston Common Asset Management LLC and OLD National Bancorp IN.

Shares of RHHBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
2/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:RHHBY
CIK
N/A
Employees
103,605
Year Founded
1896

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$68.73 billion
Cash Flow
$3.25 per share
Book Value
$5.81 per share

Miscellaneous

Outstanding Shares
6,377,936,000
Free Float
N/A
Market Cap
$262.45 billion
Optionable
Not Optionable
Beta
0.42

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:RHHBY) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners